Epstein Secrets

. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker

ed a deal to Trump, who prohibited it at the panel's recommendation." Op-Ed: The US Has Failed To Adapt To Kinds Of Global Threats. In an op-ed in the Los Angeles Times <https://www.latimes.com/opinion/story/2020-07-30/foreign-policy- threats-trump> (7/30, 4.64M), Seth G. Jones, director of the Transnational Threats

uccia, Subscription Publication, 8.41M), Politico (1/26, Cancryn, Roubein, 6.73M), and The Hill (1/26, Sullivan, Samuels, 5.69M) also have reports. Johnson & Johnson Expects To Report Vaccine Data Next Week. Reuters (1/26, Mishra, O'Donnell) reports that on Tuesday, Johnson & Johnson "said it expected to report

ew York Stock Exchange or buildings housing the CIA or FBI." Columnist: Church Bombing Hindering Anti-Hate Efforts. Gustavo Arenano, in a column in the Los Angeles Times (1/26, 3.37M), writes that supporters of the First Works Baptist Church, which espouses "antigay rhetoric of the vilest kind imaginable," are "cond

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

red a deal to Trump, who prohibited it at the panel's recommendation." Op-Ed: The US Has Failed To Adapt To Kinds Of Global Threats. In an op-ed in the Los Angeles Times (7/30, 4.64M), Seth G. Jones, director of the Transnational Threats Project at the Center for Strategic and International Studies, and Juan C. Zara

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

red a deal to Trump, who prohibited it at the panel's recommendation." Op-Ed: The US Has Failed To Adapt To Kinds Of Global Threats. In an op-ed in the Los Angeles Times (7/30, 4.64M), Seth G. Jones, director of the Transnational Threats Project at the Center for Strategic and International Studies, and Juan C. Zara